Allogeneic intra-bone marrow transplantation prevents rheumatoidarthritis in SKG/Jcl mice

Journal of Autoimmunity

Volumn 32, Issue 3-4, 2009, Pages 216-222

  Kushida, Taketoshi ^a   Ueda, Yusuke ^a   Umeda, Masayuki ^a   Oe, Kenichi ^a   Okamoto, Naofumi ^a   Iida, Hirokazu ^a   Abraham, Nader G ^b   Gershwin, M Eric ^c   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune disease; Bone marrow transplantation; SKG Jcl mouse; Stem cell

Indexed keywords

DEOXYPYRIDINOLINE; INTERLEUKIN 1; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLOGENIC BONE MARROW TRANSPLANTATION; AMINO ACID URINE LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNOPATHOLOGY; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

AMINO ACIDS; ANIMALS; ARTHRITIS, RHEUMATOID; BONE MARROW TRANSPLANTATION; FEMALE; IMMUNE TOLERANCE; INTERLEUKIN-1; INTERLEUKIN-6; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; RANK LIGAND; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67349206568     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.02.015     Document Type: Article

References (53)

1. Ikehara S., Kawamura M., Takao F., Inaba M., Yasumizu R., Than S., et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 87 (1990) 8341-8344
2. Ikehara S. Autoimmune diseases as stem cell disorders: normal stem cell transplant for their treatment. Int J Mol Med 1 (1998) 5-16 [review]
3. Ikehara S., Good R.A., Nakamura T., Sekita K., Inoue S., Oo M.M., et al. Rationale for bone marrow transplantation in the treatment of autoimmune disease. Proc Natl Acad Sci USA 82 (1985) 2483-2487
4. Ikehara S., Ohtsuki H., Good R.A., Asamoto H., Nakamura T., Sekita K., et al. Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA 82 (1985) 7743-7747
5. Oyaizu N., Yasumizu R., Inaba-Miyama M., Nomura S., Yoshida H., Miyawaki S., et al. (NZW × B × SB) F1 mouse, a new model of idiopathic thrombocytopenic purpura. J Exp Med 167 (1988) 2017-2022
6. Jacobs P., Vincent M.D., and Martell R.W. Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anemia. Bone Marrow Transplant 1 (1986) 237-239
7. Lowenthal R.M., Cohen M.L., Atkinson K., and Biggs J.C. Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 20 (1993) 137-140
8. Eedy D.J., Burrows D., Bridges J.M., and Jones F.F. Clearance of severe psoriasis after allogeneic bone marrow transplantation. Br Med J 300 (1990) 908
9. Yin J.A., and Jowitt S.N. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 9 (1992) 31-33
10. Marmont A.M. Immune ablation followed by allogeneic or autologous bone marrow transplantation. A new treatment for severe autoimmune diseases?. Stem Cells 12 (1994) 125-135
11. Nelson J.L., Torrez R., Louie F.M., Choe O.S., Storb R., and Sullivan K.M. Pre-existing autoimmune diseases in patients with long-term survival after allogeneic bone marrow transplantation. J Rheumatol 24 (1997) 23-29
12. Snowden J.A., Kearney P., Kearney A., Cooley H.M., Grigg A., Jacobs P., et al. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation. Arthritis Rheum 4 (1998) 453-459
13. Marmont A.M. Stem cell transplantation for severe autoimmune diseases: progress and problems. Haematologica 83 (1998) 733-743
14. Burt R.K. BMT for severe autoimmune diseases: an idea whose time has come. Oncology 11 (1997) 1001-1024
15. Tyndall A., Black C., Finke J., Winkler J., Mertlesmann R., Peter H.H., et al. Treatment of systemic sclerosis with autologous haematopoietic stem cell transplantation. Lancet 349 (1997) 254
16. Euler H.H., Marmont A.M., Bacigalupo A., Fastenrath S., Dreger P., Hoffknecht M., et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 88 (1996) 3621-3625
17. Ishida T.M., Inaba M., Hisha H., Sugiura K., Adachi Y., Nagata N., et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. J Immunol 152 (1994) 3119-3127
18. Hisha H., Nishino T., Kawamura M., Adachi S., and Ikehara S. Successful bone marrow transplantation by bone grafts in chimeric-resistant combination. Exp Hematol 23 (1995) 347-352
19. Hisha H., Nishino T., Kawamura M., Adachi S., and Ikehara S. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood 89 (1997) 49-54
20. Takeuchi K., Inaba M., Miyashima S., Ogawa R., and Ikehara S. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice. Blood 1998 91 (1998) 4616-4623
21. Zhang Y., Yasumizu R., Sugiura K., Hashimoto F., Amoh Y., Lian Z., et al. Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: possible explanation for the mechanism of tolerance induction by portal vein injection. Eur J Immunol 24 (1994) 1558-1565
22. Kushida T., Inaba M., Takeuchi K., Sugiura K., Ogawa R., and Ikehara S. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation. Blood 95 (2000) 1862-1868
23. Kushida T., Inaba M., Hisha H., Ichioka N., Esumi T., Ogawa R., et al. Crucial role of donor-derived stromal cells in successful treatment for intractable autoimmune diseases in MRL/lpr mice by BMT via portal vein. Stem Cells 19 (2001) 226-235
24. Kushida T., Inaba M., Hisha H., Ichioka N., Esumi T., Ogawa R., et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 97 (2001) 3292-3299
25. Ichioka N., Inaba M., Kushida T., Esumi T., Takahara K., Inaba K., et al. Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells. Stem Cells 20 (2002) 542-551
26. Ueda Y., Inaba M., Takada K., Fukui J., Sakaguchi Y., Tsuda M., et al. Induction of senile osteoporosis in normal mice by intra-bone marrow-bone marrow transplantation from osteoporosis-prone mice. Stem Cells 25 (2007) 1356-1363
27. Sakaguchi N., Takahashi T., Hata H., Nomura T., Tagami T., Yamazaki S., et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426 (2003) 454-460
28. Hata H., Sakaguchi N., Yoshitomi H., Iwakura Y., Sekikawa K., Azuma Y., et al. Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 144 (2004) 582-588
29. Yoshitomi H., Sakaguchi N., Kobayashi K., Brown G.D., Tagami T., Sakihama T., et al. A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med 21 (2005) 949-960
30. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14 (1996) 397-440
31. Katagiri T., and Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8 (2002) 147-159
32. Theill L.E., Boyle W.J., and Penninger J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Ann Rev Immunol 20 (2002) 795-823
33. Kong Y.Y., Feige U., Sarosi I., Bolon B., Tafuri A., Morony S., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 (1999) 304-309
34. Breedveld F.C., Emery P., Keystone E., Patel K., Furst D.E., Kalden J.R., et al. Infliximab in active early rheumatoid arthritis. Ann Rheum Dis 63 (2004) 149-155
35. Klareskog L., van der Heijde D., de Jager J.P., Gough A., Kalden J., Malaise M., et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 363 (2004) 675-681
36. Nishimoto N., Yoshizaki K., Miyasaka N., Yamamoto K., Kawasaki S., Takeuchi T., et al. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 50 (2004) 1761-1769
37. Cohen S., Hurd E., Cush J., Schiff M., Weinblatt M.E., Moreiand L.W., et al. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46 (2002) 614-624
38. Danis V.A., Franic G.M., Rathjen D.A., Laurent R.M., and Brooks P.M. Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine. Ann Rheum Dis 51 (1992) 946-950
39. Matsuzaki T., Nakajima A., Ishigami S., Tanno M., and Yoshino S. Mirthful laughter differentially affects sera pro- and anti-inflammatory cytokine levels depending on the level of disease activity in patients with rheumatoid arthritis. Rheumatology 45 (2006) 182-186
40. Hayashida K., Nanki T., Girschick H., Yavuz S., Ochi T., and Lipsky P.E. Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8. Arthritis Res 3 (2001) 118-126
41. Tsuboi H., Matsui Y., Hayashida K., Yamane S., Maeda-Tanimura M., Hashimoto J., et al. Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage. Ann Rheum Dis 62 (2003) 196-203
42. Li Y., Hishia H., Inaba M., Lian Z., Yu C., Kawamura M., et al. Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: a role of stromal cells in positive selection. Exp Hematol 28 (2000) 950-960
43. Ikehara S. A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases. J Autoimmun 30 (2008) 108-115
44. Ozawa K., Sato K., Oh I., Ozaki K., Uchibori R., Obara Y., et al. Cell and gene therapy using mesenchymal stem cells (MSCs). J Autoimmun 30 (2008) 121-127
45. Ratajczak M.Z., Zuba-Surma E.K., Wysoczynski M., Wan W., Ratajczak J., Wojakowski W., et al. Hunt for pluripotent stem cell - regenerative medicine search for almighty cell. J Autoimmun 30 (2008) 151-162
46. Sonoda Y. Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: the significance of the intra-bone marrow injection. J Autoimmun 30 (2008) 136-144
47. Abraham N.G., Li M., Vanella L., Peterson S.J., Ikehara S., and Asprinio D. Bone marrow stem cell transplant into intra-bone cavity prevents type 2 diabetes: role of heme oxygenase-adiponectin. J Autoimmun 30 (2008) 128-135
48. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 30 (2008) 105-107
49. Burt R.K., Testori A., Craig R., Cohen B., Suffit R., and Barr W. Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?. J Autoimmun 30 (2008) 116-120
50. Rezvani A.R., and Storb R.F. Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. J Autoimmun 30 (2008) 172-179
51. Deane S., Meyers F.J., and Gershwin M.E. On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years. J Autoimmun 30 (2008) 180-196
52. Xia C.Q., Qiu Y., Peng R.H., Lo-Dauer J., and Clare-Salzler M.J. Infusion of UVB-treated splenic stromal cells induces suppression of beta cell antigen-specific T cell responses in NOD mice. J Autoimmun 30 (2008) 283-292
53. Marmont A.M. Will hematopoietic stem cell transplantation cure human autoimmune diseases?. J Autoimmun 30 (2008) 145-150